Design Therapeutics, Inc.
Extracted from this filing and checked against the source text.
Design Therapeutics, Inc. shareholders approved Election of Director at the 2026-06-09 meeting.
Proposal 1. Election of Director The Company’s stockholders elected the one person listed below as a Class II director, to serve until the Company’s 2029 Annual Meeting of Stockholders and until his successor is duly elected and qualified, or, if sooner, until his death, resignation or removal. The final voting results are as follows: Votes For Votes Withheld Broker Non-Votes Simeon George, M.D. 29,205,208 7,608,724 13,264,883View on SEC.gov
Design Therapeutics, Inc. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.
Proposal 2. Ratification of Selection of Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The final voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 50,077,708 201 906 Not applicableView on SEC.gov
1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.